Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis

KB Lo, R Bhargav, G Salacup, J Pelayo… - Expert Review of …, 2020 - Taylor & Francis
Background The use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in patients with coronavirus disease 2019 (COVID-19) given their …
被引用次数：36 相关文章

Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis

KB Lo, R Bhargav, G Salacup… - Expert review of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in patients with coronavirus disease 2019 (COVID-19) given their …

Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis.

KB Lo, R Bhargav, G Salacup, J Pelayo… - Expert Review of …, 2020 - europepmc.org
Background The use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II
receptor blockers (ARB) in patients with coronavirus disease 2019 (COVID-19) given their …